UnitedHealth Group has named the head of its Medicare business as the CEO of its insurance business, succeeding the Brian Thompson, who was shot and killed on Dec. 4 in New York City while walking to ...

An investigational higher dose of spinal muscular atrophy drug nusinersen gains attention as the FDA and European Medicines Agency (EMA) considerate it as an alternative than the current lower ...

The FDA recently granted marketing authorization for the TriVerity Test System — a new molecular diagnostic test developed by Inflammatix. This first-of-its-kind test provides a comprehensive ...

Ways workplaces and insurance companies have begun to support menopausal women, according to Jenifer Allbright, director of G&A Beneficial.

Regulatory officials have identified 82 cases worldwide from the FDA Adverse Event Reporting System of anaphylaxis associated ...

The investigational advanced melanoma combination therapy consisting of RP1 and nivolumab have a PDUFA action date of July 22 ...

Human Metapneumovirus (HMPV) is a respiratory virus that may not be on most folk’s radars, but it’s more common than you ...

Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...

One-third of folks with major depressive disorder experience treatment-resistant depression (TRD), a condition that makes it ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of ...

A panelist discusses how she carefully transitions patients to neurokinin-targeted therapies by establishing realistic timelines for symptom improvement and actively monitoring patient response while ...

In a phase 2 clinical trial, researchers examined baricitinib and NB-UVB in adults with severe vitiligo in the dermatology ...